Andrew H. Sassine's Insider Trades & SAST Disclosures
Andrew H. Sassine's most recent trade in Icad Inc was a trade of 30,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Andrew H. Sassine.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 30,000 | 30,000 | - | - | Director Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Andrew Sassine H. | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 27,586 | 27,586 | - | - | Director Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Andrew H. Sassine | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.03 per share. | 12 Jun 2024 | 50,000 | 220,526 (1%) | 0% | 32.0 | 1,601,500 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 25,259 | 25,259 | - | - | Director Stock Option (right to buy) | |
| Icad Inc | H. Sassine Andrew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 30,265 | 30,265 | - | - | Director Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 30,000 | 30,000 | - | - | Director Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | H. Andrew Sassine | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Andrew H. Sassine | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 17.37 per share. | 15 Aug 2023 | 1,223 | 270,526 (1%) | 0% | 17.4 | 21,248 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 12,954 | 12,954 | - | - | Director Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2023 | 28,774 | 28,774 | - | - | Director Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 30,000 | 30,000 | - | - | Director Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Andrew H. Sassine | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Andrew H. Sassine | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 18.42 per share. | 15 Aug 2022 | 1,068 | 269,303 (1%) | 0% | 18.4 | 19,672 | Common Stock |
| Arcturus Therapeutics Hold... | Andrew H. Sassine | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 85,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 5.26 per share. | 07 Feb 2022 | 10,000 | 1,208,382 (5%) | 0% | 5.3 | 52,600 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 5.49 per share. | 07 Feb 2022 | 10,000 | 1,198,382 (5%) | 0% | 5.5 | 54,900 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 6.20 per share. | 06 Jan 2022 | 10,000 | 1,228,382 (5%) | 0% | 6.2 | 62,000 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 6.07 per share. | 06 Jan 2022 | 10,000 | 1,218,382 (5%) | 0% | 6.1 | 60,700 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 30,000 | 30,000 | - | - | Director Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 6.71 per share. | 06 Dec 2021 | 10,000 | 1,248,382 (5%) | 0% | 6.7 | 67,100 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 06 Dec 2021 | 10,000 | 1,238,382 (5%) | 0% | 7.3 | 72,800 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 10.30 per share. | 08 Nov 2021 | 10,000 | 1,258,382 (5%) | 0% | 10.3 | 103,000 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 10.89 per share. | 08 Nov 2021 | 10,000 | 1,268,382 (6%) | 0% | 10.9 | 108,900 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 10.56 per share. | 06 Oct 2021 | 10,000 | 1,288,382 (6%) | 0% | 10.6 | 105,600 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 10.42 per share. | 06 Oct 2021 | 10,000 | 1,278,382 (6%) | 0% | 10.4 | 104,200 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 10.68 per share. | 13 Sep 2021 | 10,000 | 1,298,382 (6%) | 0% | 10.7 | 106,800 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 11.09 per share. | 13 Sep 2021 | 10,000 | 1,308,382 (6%) | 0% | 11.1 | 110,900 | Common Stock |
| Exicure Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Exicure Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 30,000 | 30,000 | - | - | Stock Option | |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 3,500 | 1,318,382 (6%) | 0% | - | Common Stock | |
| Arcturus Therapeutics Hold... | Andrew H. Sassine | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 4,002 | 4,002 | - | - | Director Stock Option (right to buy) | |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 9.47 per share. | 08 Sep 2020 | 10,000 | 1,314,882 (6%) | 0% | 9.5 | 94,746 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 08 Sep 2020 | 10,000 | 1,324,882 (6%) | 0% | 9.4 | 93,977 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 10.28 per share. | 06 Aug 2020 | 10,000 | 1,334,882 (6%) | 0% | 10.3 | 102,821 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 10.31 per share. | 06 Aug 2020 | 10,000 | 1,344,882 (6%) | 0% | 10.3 | 103,079 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 9.48 per share. | 13 Jul 2020 | 10,000 | 1,354,882 (6%) | 0% | 9.5 | 94,754 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Sale of securities on an exchange or to another person at price $ 9.53 per share. | 13 Jul 2020 | 10,000 | 1,364,882 (6%) | 0% | 9.5 | 95,300 | Common Stock |
| Icad Inc | Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 3,542 | 3,542 | - | - | Director Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Andrew H. Sassine | Director, Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 29.74 per share. | 10 Jun 2020 | 5,000 | 273,245 (1%) | 0% | 29.7 | 148,700 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges